Proteome Sciences (LON:PRM) Trading Down 9.8% – What’s Next?
by Michael Walen · The Markets DailyProteome Sciences plc (LON:PRM – Get Free Report)’s share price was down 9.8% on Wednesday . The company traded as low as GBX 3.18 ($0.04) and last traded at GBX 3.18 ($0.04). Approximately 41,420 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 91,685 shares. The stock had previously closed at GBX 3.52 ($0.04).
Proteome Sciences Stock Performance
The firm has a market capitalization of £9.37 million, a PE ratio of -317.50 and a beta of 0.07. The firm’s 50 day moving average price is GBX 2.90 and its 200-day moving average price is GBX 3.12.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Conference Calls and Individual Investors
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Canadian Penny Stocks: Can They Make You Rich?
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider